Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huidi Liu

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 6, 2025
The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunityHao Wu, Jiena Liu, Xing-Hua Zhang, et al.
Virology|June 3, 2025
Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallateMeng-Chun Zhang, Hao Wu, Jiaxing Wang, et al.
Journal of Natural Products|April 11, 2024
Cannabidiol Inhibits Epithelial Ovarian Cancer: Role of Gut MicrobiomeDanli Cao, Yiru Lin, Caiji Lin, et al.
British Journal of Pharmacology|November 13, 2025
Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosisDanli Cao, Caiji Lin, Jiaxing Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 22, 2026
Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathwayShuhui Chai, Yihang Zhang, Yi Guo, et al.
Journal of Ovarian Research|July 26, 2017
Enterolactone has stronger effects than enterodiol on ovarian cancerHuidi Liu, Jianrui Liu, Siwen Wang, et al.
British Journal of Pharmacology|February 12, 2026
Enterolactone and THBS1-3TSR synergistically inhibit ovarian cancer and suppress angiogenesis in the tumour microenvironmentCaiji Lin, Jiaxing Wang, Shuhui Chai, et al.
Cancer Biology & Therapy|November 28, 2017
Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9Huidi Liu, Zheng Zeng, Siwen Wang, et al.
Scientific Reports|May 19, 2016
SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancerHuidi Liu, Emilio Mastriani, Zi-Qiao Yan, et al.
Phytotherapy Research : PTR|July 14, 2023
Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1Zheng Zeng, Caiji Lin, Meng-Chun Zhang, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 6, 2025
The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunityHao Wu, Jiena Liu, Xing-Hua Zhang, et al.
Virology|June 3, 2025
Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallateMeng-Chun Zhang, Hao Wu, Jiaxing Wang, et al.
Journal of Natural Products|April 11, 2024
Cannabidiol Inhibits Epithelial Ovarian Cancer: Role of Gut MicrobiomeDanli Cao, Yiru Lin, Caiji Lin, et al.
British Journal of Pharmacology|November 13, 2025
Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosisDanli Cao, Caiji Lin, Jiaxing Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 22, 2026
Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathwayShuhui Chai, Yihang Zhang, Yi Guo, et al.
Journal of Ovarian Research|July 26, 2017
Enterolactone has stronger effects than enterodiol on ovarian cancerHuidi Liu, Jianrui Liu, Siwen Wang, et al.
British Journal of Pharmacology|February 12, 2026
Enterolactone and THBS1-3TSR synergistically inhibit ovarian cancer and suppress angiogenesis in the tumour microenvironmentCaiji Lin, Jiaxing Wang, Shuhui Chai, et al.
Cancer Biology & Therapy|November 28, 2017
Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9Huidi Liu, Zheng Zeng, Siwen Wang, et al.
Scientific Reports|May 19, 2016
SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancerHuidi Liu, Emilio Mastriani, Zi-Qiao Yan, et al.
Phytotherapy Research : PTR|July 14, 2023
Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1Zheng Zeng, Caiji Lin, Meng-Chun Zhang, et al.
Pageof 6